您的位置: 首页 > 农业专利 > 详情页

NOVA IMUNOTERAPIJA ZA LEČENJE NEKOLIKO TUMORA KRVI, POSEBNO HRONIČNE LIMFOCITNE LEUKEMIJE (HLL)
专利权人:
IMMATICS BIOTECHNOLOGIES GMBH
发明人:
STICKEL, JULIANE,KOWALEWSKI, DANIEL,RAMMENSEE, HANS-GEORG,STEVANOVIC, STEFAN
申请号:
RSP20200910
公开号:
RS60592B1
申请日:
2015.06.17
申请国别(地区):
RS
年份:
2020
代理人:
摘要:
Provided are peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. Provided are also tumor-associated cytotoxic T cell (CTL) peptide epitopes that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. Provided are several peptide sequences derived from HLA class I and HLA class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充